Gilead Sciences Inc at JPMorgan Healthcare Conference (Virtual) Transcript
All right. Good afternoon, everyone, from the virtual JPMorgan Healthcare Conference. My name is Cory Kasimov. I'm the senior large-cap biotech analyst, and it's my pleasure to introduce our next company, Gilead, and Chairman and CEO, Dan O'Day.
Please note that following this presentation, we will have a Q&A session right here in the same Zoom room, and you're able to submit your own questions via the little blue ask-a-question button in the conference portal. So please do that throughout the presentation. We'll get to as many as we can after Dan is finished.
So with that, Dan, thanks for being here today, and let me turn things over to you.
' -
Great. Thanks, Cory and JPMorgan, for hosting us here. Really appreciate the opportunity to speak to you about Gilead. It is -- just 1 year ago, that was my first JPMorgan with Gilead, and a lot has happened in that year time,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
